BlackRock’s Burning Rock Biotech BNR Stock Holding History

BlackRock’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33	Hold	4	–	–	﹤0.01%	5647
2026 Q1	$65	Sell	4 -6	-60%	-$157	﹤0.01%	5624
2025 Q4	$202	Hold	10	–	–	﹤0.01%	5458
2025 Q3	$87	Hold	10	–	–	﹤0.01%	5407
2025 Q2	$32	Hold	10	–	–	﹤0.01%	5425
2025 Q1	$45	Buy	10 +4	+67%	+$25	﹤0.01%	5390
2024 Q4	$41	Hold	6	–	–	﹤0.01%	5363
2024 Q3	$20	Hold	6	–	–	﹤0.01%	5201
2024 Q2	$39	Sell	6 -1	-14%	-$8	﹤0.01%	5256
2024 Q1	$47	Hold	7	–	–	﹤0.01%	5263
2023 Q4	$60	Sell	7 -131	-95%	-$1.21K	﹤0.01%	5340
2023 Q3	$1.34K	Sell	138 -4,054	-97%	-$63.3K	﹤0.01%	5315
2023 Q2	$90.1K	Hold	4,192	–	–	﹤0.01%	4946
2023 Q1	$118K	Sell	4,192 -1,015	-19%	-$30.4K	﹤0.01%	4921
2022 Q4	$117K	Sell	5,207 -150,599	-97%	-$3.44M	﹤0.01%	4992
2022 Q3	$3.72M	Sell	155,806 -7,146	-4%	-$231K	﹤0.01%	3888
2022 Q2	$4.74M	Buy	162,952 +19,277	+13%	+$861K	﹤0.01%	3843
2022 Q1	$13.3M	Buy	143,675 +14,053	+11%	+$1.22M	﹤0.01%	3420
2021 Q4	$12.4M	Sell	129,622 -54,301	-30%	-$7.44M	﹤0.01%	3547
2021 Q3	$32.9M	Buy	183,923 +10,392	+6%	+$2.31M	﹤0.01%	2939
2021 Q2	$51.1M	Buy	+173,531	New	+$51.3M	﹤0.01%	2690

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's BNR Position: Q2 2026 in Review

BlackRock held its Burning Rock Biotech (BNR) position steady in Q2 2026 at 4 shares worth $33. The position accounts for ﹤0.01% of the portfolio, ranked #5647.

BlackRock first reported a position in BNR in Q2 2021 and has held it in 21 quarters since. The position peaked at $51.1M in Q2 2021. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

BlackRock held 4 shares of Burning Rock Biotech worth $33 as of Q2 2026.
BlackRock left its Burning Rock Biotech share count unchanged in Q2 2026.
Burning Rock Biotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5647 holding.
BlackRock first reported a position in Burning Rock Biotech in Q2 2021 and has held it in 21 quarters since.
BlackRock's Burning Rock Biotech position peaked at $51.1M in Q2 2021.
17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.